Debbie S. Gipson

19.9k total citations · 1 hit paper
145 papers, 5.7k citations indexed

About

Debbie S. Gipson is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Speech and Hearing. According to data from OpenAlex, Debbie S. Gipson has authored 145 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Nephrology, 34 papers in Pediatrics, Perinatology and Child Health and 27 papers in Speech and Hearing. Recurrent topics in Debbie S. Gipson's work include Renal Diseases and Glomerulopathies (66 papers), Chronic Kidney Disease and Diabetes (38 papers) and Adolescent and Pediatric Healthcare (27 papers). Debbie S. Gipson is often cited by papers focused on Renal Diseases and Glomerulopathies (66 papers), Chronic Kidney Disease and Diabetes (38 papers) and Adolescent and Pediatric Healthcare (27 papers). Debbie S. Gipson collaborates with scholars based in United States, Canada and United Kingdom. Debbie S. Gipson's co-authors include Howard Trachtman, Rebecca M. Lombel, Stephen R. Hooper, Elisabeth M Hodson, María Ferris, David T. Selewski, Bradley A. Warady, Marva Moxey‐Mims, Jonathan P. Troost and Susan L. Furth and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Debbie S. Gipson

141 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations Kirk N. Campbell, Debbie S. Gipson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debbie S. Gipson United States	42	3.5k	1.2k	765	750	750	145	5.7k
Marva Moxey‐Mims United States	38	2.7k 0.8×	2.0k 1.7×	339 0.4×	600 0.8×	391 0.5×	101	5.6k
Elke Wühl Germany	38	1.5k 0.4×	1.7k 1.4×	222 0.3×	917 1.2×	101 0.1×	114	6.4k
Alison M. MacLeod United Kingdom	32	3.7k 1.1×	538 0.4×	522 0.7×	315 0.4×	40 0.1×	117	5.6k
Maria Grazia Valsecchi Italy	49	316 0.1×	2.4k 2.0×	460 0.6×	959 1.3×	226 0.3×	246	7.7k
Nancy E. Fink United States	43	4.2k 1.2×	399 0.3×	194 0.3×	148 0.2×	149 0.2×	89	7.2k
Jaap Fransen Netherlands	46	332 0.1×	340 0.3×	1.5k 2.0×	458 0.6×	102 0.1×	144	8.6k
Eswar Krishnan United States	50	2.9k 0.8×	190 0.2×	1.5k 2.0×	906 1.2×	55 0.1×	113	7.5k
Faith D. Ottery United States	24	292 0.1×	573 0.5×	289 0.4×	980 1.3×	253 0.3×	75	6.6k
Elisabeth R. Mathiesen Denmark	50	1.4k 0.4×	2.8k 2.3×	158 0.2×	896 1.2×	65 0.1×	251	11.1k
Rupesh Raina United States	34	1.1k 0.3×	372 0.3×	120 0.2×	399 0.5×	61 0.1×	242	3.9k

Countries citing papers authored by Debbie S. Gipson

Since Specialization

Citations

This map shows the geographic impact of Debbie S. Gipson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie S. Gipson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie S. Gipson more than expected).

Fields of papers citing papers by Debbie S. Gipson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie S. Gipson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie S. Gipson. The network helps show where Debbie S. Gipson may publish in the future.

Co-authorship network of co-authors of Debbie S. Gipson

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie S. Gipson. A scholar is included among the top collaborators of Debbie S. Gipson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie S. Gipson. Debbie S. Gipson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larkina, Maria, Margaret Helmuth, Damian Fermin, et al.. (2023). The Significance of Hematuria in Podocytopathies. Clinical Journal of the American Society of Nephrology. 19(1). 56–66. 1 indexed citations

Gipson, Debbie S., Hailey Desmond, Charles E. Anderson, et al.. (2023). Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome. SHILAP Revista de lepidopterología. 3(1). 132–139. 1 indexed citations

Filler, Guido, et al.. (2022). Artificial Intelligence in Pediatric Nephrology—A Call for Action. PubMed. 30(1). 17–24. 9 indexed citations

Srivastava, Tarak, Katherine M. Dell, Kevin V. Lemley, et al.. (2022). Gluten-Free Diet in Childhood Difficult-to-Treat Nephrotic Syndrome: A Pilot Feasibility Study. SHILAP Revista de lepidopterología. 2(4). 176–183. 1 indexed citations

Hanson, Camilla S., Simon Carter, Allison Tong, et al.. (2022). Perspectives of Clinicians on Shared Decision Making in Pediatric CKD: A Qualitative Study. American Journal of Kidney Diseases. 80(2). 241–250. 5 indexed citations

Ferris, María, et al.. (2021). Health-related quality of life in children with chronic kidney disease is affected by the number of medications. Pediatric Nephrology. 36(5). 1307–1310. 6 indexed citations

Eikstadt, Richard, Hailey Desmond, Cheryl Courtlandt, et al.. (2021). The Development and Use of an EHR-Linked Database for Glomerular Disease Research and Quality Initiatives. PubMed Central. 1(4). 173–179. 2 indexed citations

Trachtman, Howard, Debbie S. Gipson, Kevin V. Lemley, et al.. (2019). Plasma Zonulin Levels in Childhood Nephrotic Syndrome. Frontiers in Pediatrics. 7. 197–197. 11 indexed citations

Trachtman, Howard, Peter J. Nelson, Sharon G. Adler, et al.. (2018). DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. Journal of the American Society of Nephrology. 29(11). 2745–2754. 129 indexed citations

10.

Hooper, Stephen R., Arlene C. Gerson, Rebecca J. Johnson, et al.. (2016). Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease. Journal of Developmental & Behavioral Pediatrics. 37(3). 231–238. 28 indexed citations

11.

Spino, Cathie, et al.. (2016). Changing the Paradigm for the Treatment and Development of New Therapies for FSGS. Frontiers in Pediatrics. 4. 25–25. 9 indexed citations

12.

Hogg, Ronald J., R. Curtis Bay, J. Charles Jennette, et al.. (2015). Randomized Controlled Trial of Mycophenolate Mofetil in Children, Adolescents, and Adults With IgA Nephropathy. American Journal of Kidney Diseases. 66(5). 783–791. 81 indexed citations

13.

Mariani, Laura H., Shiv Kapoor, Jidong Zhang, et al.. (2014). A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney International. 87(3). 564–574. 91 indexed citations

14.

Ferris, María, J. Bradley Layton, Michael T Ferris, et al.. (2012). A Clinical Tool to Measure the Components of Health-Care Transition from Pediatric Care to Adult Care: TheUNC TR_xANSITION Scale. Renal Failure. 34(6). 744–753. 131 indexed citations

15.

Wei, Changli, Howard Trachtman, Jing Li, et al.. (2012). Circulating suPAR in Two Cohorts of Primary FSGS. Journal of the American Society of Nephrology. 23(12). 2051–2059. 158 indexed citations

16.

Trachtman, Howard, Suzanne Vento, Debbie S. Gipson, et al.. (2011). Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC Nephrology. 12(1). 8–8. 29 indexed citations

17.

Gipson, Debbie S., Howard Trachtman, Frederick J. Kaskel, et al.. (2010). Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney International. 79(6). 678–685. 37 indexed citations

18.

Gipson, Debbie S., et al.. (2006). The central nervous system in childhood chronic kidney disease. Pediatric Nephrology. 22(10). 1703–1710. 34 indexed citations

19.

Gipson, Debbie S., Keisha L. Gibson, Patrick E. Gipson, Sandra Watkins, & Marva Moxey‐Mims. (2006). Therapeutic approach to FSGS in children. Pediatric Nephrology. 22(1). 28–36. 28 indexed citations

20.

Wong, Craig S., Debbie S. Gipson, Daniel L. Gillen, et al.. (2000). Anthropometric measures and risk of death in children with end-stage renal disease. American Journal of Kidney Diseases. 36(4). 811–819. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact